Novartis Expands Antibiotics Manufacturing Site
By

By
Lek, a Sandoz company and part of Novartis, is investing to expand production of broad-spectrum antibiotics at Novartis’ penicillin site in Prevalje, Slovenia. Sandoz is the generic drug arm of…

Almac Invests in Ireland Facility
By

By
Almac Group, a Craigavon, Ireland-based contract pharmaceutical development and manufacturing organization, has announced an expansion in Dundalk, County Louth, Ireland, where it has secured premises to build a new facility.…

Vetter Starts Temperature-Storage Operations
By

By
Vetter, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling, and final packaging of injectables, has begun operations in its expanded visual inspection and logistics center in Ravensburg.…

Sanofi, Enteris to Develop Oral Diabetes Therapy
By

By
Sanofi has initiated a feasibility study agreement with Enteris BioPharma, a Boonton, New Jersey-headquartered biotechnology company, which will leverage Enteris’ proprietary and patented oral peptide and small-molecule delivery platform, Peptelligence,…

Ropack Partners with TraceLink for Serialization
By

By
Ropack Pharma Solutions, a Montreal, Quebec, Canada-headquartered contract development and manufacturing organization, has selected TraceLink, a North Reading, Massachusetts-based track-and-trace solutions provider, to provide serialization solutions for Ropack’s customers using TraceLink’s…

Sharp, Ashfield to Launch Diurnal’s Pediatric Drug
By

By
Diurnal Group, a Cardiff, UK-headquartered specialty pharmaceutical company targeting chronic endocrine diseases, has signed agreements with Sharp Packaging Services and Ashfield Healthcare, divisions of UDG Healthcare, a Dublin, Ireland-headquartered contract…

Almac Launches Temperature-Management Software
By

By
Almac Group, a Craigavon, Ireland-based contract pharmaceutical development and manufacturing organization, has launched new temperature-management software, TempEZ, a GDP (good distribution practice)-compliant web-based platform that provides a single database to store…

PhRMA Comments on Meeting with President Trump
By

By
US President Donald Trump met with pharmaceutical industry executives and representatives from Pharmaceutical Research and Manufacturers of America (PhRMA) at the White House this week to discuss issues of common interest,…

Lilly Terminates $570-Million Insulin Partnership
By

By
Eli Lilly and Company has terminated its $570-million collaboration research and license agreement with Adocia, a Lyon, France-headquartered clinical-stage biopharmaceutical company that specializes in developing new formulations for already approved…

Lundbeck, IBM Watson in Neurological Pact
By

By
H. Lundbeck, a Valby, Denmark-based pharmaceutical company specializing in psychiatric and neurological disorders, has formed a collaboration with IBM’s Watson Health for developing medicines to treat psychiatric and neurological disorders,…